Geriatrics
Update
On site
Online

Date
Tuesday, May 5, 2026
Time
08:00 – 08:45
Duration
45 min
Credits
1 CME credit
Language
English
Objectives
This talk will discuss necessary ethical principles for the design of digital health technologies for individuals with cognitive impairments.
Provider
Klinik Barmelweid
On site
Online
As a webinar on geriatrics-update.com. You’ll receive the access link by email in advance or directly on this page.
Dr. Rasita Vinay,
Postdoctoral Researcher, Core Director for Digital Ethics and Care for Older Adults, Centre for Digital Health Interventions, University of Zurich, ETH Zürich
Dr. Vinay is a Postdoctoral Researcher (Faculty of Medicine, University of Zurich) and Core Director for Care for Older Adults and Digital Ethics (CDHI, ETH Zurich). She has a background in biomedical ethics (MA) and neuroscience (BSc), and her research focuses on conversational agents for vulnerable older populations, such as those with cognitive impairments. She is currently leading the GRACE project, funded by the Swiss National Science Foundation until 2029. Additionally, Dr. Vinay is a lecturer at ETH Zurich for the CAS in Digital Health.
Ethics is embedded from project start
Ethical co-design embeds ethics from the earliest innovation stages, not as post-hoc compliance. It addresses autonomy, dignity, privacy, bias, accountability, harm prevention, and relational effects, which are particularly relevant when designing digital health interventions for cognitively impaired individuals.
Co-design includes users as moral stakeholders
Ethical co-design goes beyond user-centered usability testing. It includes cognitively impaired individuals, caregivers, and professionals in inclusive co-design sessions to identify stakeholder values, contextual trade-offs, communication preferences, and ethical boundaries for digital health interventions.
Evaluation remains iterative and accountable
The framework combines ethical framing, participatory engagement, evaluation, and iterative reflexivity. In the GRACE case, trustworthiness criteria, simulated interactions, and documentation of trade-offs support accountable design, including balancing proactivity, user control, emotional engagement, and non-deceptiveness.
In the continuing education session “An Ethical Approach to Co-design Scalable Digital Health Interventions for Cognitively Impaired Individuals,” Dr. Rosita Vinay presents a framework for integrating ethics directly into the design, testing, implementation, and scaling of digital health interventions for people with cognitive impairment. Organized by Klinik Barmelweid, the session emphasizes that older adults with cognitive decline are often underrepresented in research and development, which risks reinforcing structural inequities when technologies are deployed at scale. Dr. Vinay distinguishes ethical co-design from conventional user-centered design by arguing that affected individuals should not function merely as end-product testers, but as moral stakeholders and active contributors within participatory research processes. She describes the proposed framework as combining ethics by design, value sensitive design, and the European Commission’s ALTAI checklist in order to link normative ethical principles, stakeholder values, and evaluative accountability structures. As a case study, she discusses GRACE, a voice-based conversational agent developed to support people with early dementia through meaningful conversation and cognitive stimulation therapy, while also considering caregiver burden and aging in place. The presentation shows how ethical framing, participatory engagement, evaluation, accountability, and iterative reflexivity are applied in the GRACE project to address issues such as autonomy, dignity, deception, trustworthiness, inclusivity, and user control. In conclusion, Dr. Vinay argues that ethics does not constrain innovation, but functions as an enabling condition for inclusive, trustworthy, and scalable digital health technologies, and she notes current developments in Switzerland regarding reimbursement structures for digital therapeutics.